LONNEL COATS

CIK 1612528 · Chief Executive Officer · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.23M

Companies

4

Total Filings

52

Lifetime Open-Market Net

-$1.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RLAY Director $14.81 $0 2 2026-06-10
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 5 2025-07-28
Blueprint Medicines Corp (BPMC) Delisted Director 0 $129.46 $0 -$2.69M 15 2025-07-21
LXRX Chief Executive Officer 1,159,439 $1.92 $2.23M $1.11M 30 2024-02-29

Recent Filings · Page 4 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-10 LXRX Grant (A) $0 EDGAR
2019-09-19 LXRX Buy (P) +50,000 $155.0K EDGAR
2019-09-18 LXRX Buy (P) +50,000 $156.4K EDGAR
2019-08-20 LXRX Buy (P) +40,000 $54.0K EDGAR
2019-08-19 Blueprint Medicines Corp (BPMC) Delisted Mixed -$673.9K EDGAR
2019-06-20 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
2019-03-01 LXRX Mixed +29,460 -$102.7K EDGAR
2019-02-08 LXRX Grant (A) $0 EDGAR
2018-06-25 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
2018-03-02 LXRX Mixed +15,094 -$81.0K EDGAR
Showing 3140 of 52
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.